M Kawaguchi1, Y Mitsuhashi, S Kondo. 1. Department of Dermatology, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata 990-9585, Japan.
Abstract
BACKGROUND: Tumour necrosis factor (TNF)-alpha-converting enzyme (TACE) is a metalloproteinase-disintegrin that releases soluble TNF-alpha from cells by cleaving within the extracellular domain of membrane-bound pro-TNF-alpha. It was proposed that TNF-alpha is involved in the pathogenesis of psoriasis, and it is therefore suggested that TACE has important roles in psoriasis. However, it is unclear whether TACE is expressed in psoriatic tissue. OBJECTIVES: To clarify whether TACE is expressed in psoriatic lesions and whether expression levels of TACE mRNA are increased in lesional compared with nonlesional psoriatic skin. METHODS: Skin biopsies were obtained from patients with psoriasis. We examined the expression of TACE in psoriatic tissues using a novel real-time quantitative reverse transcriptase-polymerase chain reaction method and immunohistochemical analysis. RESULTS: There was a significant rise in the level of TACE mRNA expression in lesional psoriatic skin compared with nonlesional skin in all patients. There was a statistically significant rise in the level of TACE mRNA expression in lesional psoriatic skin compared with nonlesional skin (mean +/- SD TACE/glyceraldehyde-3-phosphate dehydrogenase ratio 0.031 +/- 0.012 vs. 0.009 +/- 0.002, P < 0.05). In lesional psoriatic skin, immunostaining with anti-TACE antibody was present throughout all layers of the epidermis. TACE immunostaining was found in the cytoplasm of keratinocytes. There was staining associated with blood vessels in the papillary dermis and perivascular inflammatory cells. In particular, mast cells showed strong staining. They contained numerous granules that were stained for TACE in the cytoplasm. CONCLUSIONS: The findings of the present study suggest that elevation of TACE mRNA in psoriatic lesions is due to many cells, particularly mast cells, that function in lesional psoriatic skin as an important source of TNF-alpha and other cytokines.
BACKGROUND:Tumour necrosis factor (TNF)-alpha-converting enzyme (TACE) is a metalloproteinase-disintegrin that releases soluble TNF-alpha from cells by cleaving within the extracellular domain of membrane-bound pro-TNF-alpha. It was proposed that TNF-alpha is involved in the pathogenesis of psoriasis, and it is therefore suggested that TACE has important roles in psoriasis. However, it is unclear whether TACE is expressed in psoriatic tissue. OBJECTIVES: To clarify whether TACE is expressed in psoriatic lesions and whether expression levels of TACE mRNA are increased in lesional compared with nonlesional psoriatic skin. METHODS: Skin biopsies were obtained from patients with psoriasis. We examined the expression of TACE in psoriatic tissues using a novel real-time quantitative reverse transcriptase-polymerase chain reaction method and immunohistochemical analysis. RESULTS: There was a significant rise in the level of TACE mRNA expression in lesional psoriatic skin compared with nonlesional skin in all patients. There was a statistically significant rise in the level of TACE mRNA expression in lesional psoriatic skin compared with nonlesional skin (mean +/- SD TACE/glyceraldehyde-3-phosphate dehydrogenase ratio 0.031 +/- 0.012 vs. 0.009 +/- 0.002, P < 0.05). In lesional psoriatic skin, immunostaining with anti-TACE antibody was present throughout all layers of the epidermis. TACE immunostaining was found in the cytoplasm of keratinocytes. There was staining associated with blood vessels in the papillary dermis and perivascular inflammatory cells. In particular, mast cells showed strong staining. They contained numerous granules that were stained for TACE in the cytoplasm. CONCLUSIONS: The findings of the present study suggest that elevation of TACE mRNA in psoriatic lesions is due to many cells, particularly mast cells, that function in lesional psoriatic skin as an important source of TNF-alpha and other cytokines.
Authors: Dmitri Gourevitch; Andrew V Kossenkov; Yong Zhang; Lise Clark; Celia Chang; Louise C Showe; Ellen Heber-Katz Journal: Adv Wound Care (New Rochelle) Date: 2014-09-01 Impact factor: 4.730
Authors: Daniela Kugelmann; Maresa Anders; Anna M Sigmund; Desalegn T Egu; Ramona A Eichkorn; Amir S Yazdi; Miklós Sárdy; Michael Hertl; Dario Didona; Takashi Hashimoto; Jens Waschke Journal: Front Immunol Date: 2022-06-30 Impact factor: 8.786
Authors: Adam S Nabatian; Muhammad M Bashir; Maria Wysocka; Meena Sharma; Victoria P Werth Journal: Arthritis Res Ther Date: 2012-01-04 Impact factor: 5.156